In phase 2 trials, cendifensine significantly reduced the frequency and severity of menopausal hot flashes and may offer broader symptom benefits.
Rebecca Dunsmoor-Su, MD
Advertisement
Rebecca Dunsmoor-Su, MD, is the Chief Medical Officer for Gennev.
Articles by Rebecca Dunsmoor-Su, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Maternal vitamin D levels during pregnancy linked to dental caries risk in offspring
2
NAD-related metabolites are potential biomarkers for recurrent pregnancy loss
3
Endometriosis found more prevalent than adenomyosis
4
How invisible symptoms and provider bias delay endometriosis diagnosis
5
